Evidence map›Paper›PMID 23754627›Full record

ReviewWiley interdisciplinary reviews. RNA

Non-mRNA 3' end formation: how the other half lives.

Natoya Peart, Anupama Sataluri, David Baillat, Eric J Wagner

Open access · greenAbstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. RNA. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. SnoRNAs: Exploring Their Implication in Human Diseases.International journal of molecular sciences · 2024
    Review
  2. Generation ofDevelopment & reproduction · 2023
    Article
  3. Article
  4. Review
  5. The Integrator Complex in Transcription and Development.Trends in biochemical sciences · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Long non-coding RNAs in cancer and development: where do we go from here?International journal of molecular sciences · 2015
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Natoya PeartDepartment of Biochemistry and Molecular Biology, The University of Texas Medical School at Houston, TX, USA.
Anupama Sataluri
David Baillat
Eric J Wagner
Houston Graduate School of Theology · USTexas Medical Center · USThe University of Texas Health Science Center at Houston · USUniversity of Houston · US

Funding

A HTS Assay for Inhibitors of Proximal Cleavage and PolyadenylationR01CA166274 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI WAGNER, ERIC J · 2012 to 2014
$821k
NCI NIH HHS CA166274NCI NIH HHS R01 CA166274
6 · The paper itself

Abstract

The release of nascent RNA from transcribing RNA polymerase complexes is required for all further functions carried out by RNA molecules. The elements and processing machinery involved in 3' end formation therefore represent key determinants in the biogenesis and accumulation of cellular RNA. While these factors have been well-characterized for messenger RNA, recent work has elucidated analogous pathways for the 3' end formation of other important cellular RNA. Here, we discuss four specific cases of non-mRNA 3' end formation-metazoan small nuclear RNA, Saccharomyces cerevisiae small nuclear RNA, Schizosaccharomyces pombe telomerase RNA, and the mammalian MALAT1 large noncoding RNA-as models of alternative mechanisms to generate RNA 3' ends. Comparison of these disparate processing pathways reveals an emerging theme of evolutionary ingenuity. In some instances, evidence for the creation of a dedicated processing complex exists; while in others, components are utilized from the existing RNA processing machinery and modified to custom fit the unique needs of the RNA substrate. Regardless of the details of how non-mRNA 3' ends are formed, the lengths to which biological systems will go to release nascent transcripts from their DNA templates are fundamental for cell survival.

Indexed as

HumansMetabolic Networks and PathwaysModels, BiologicalRNARNA, Long NoncodingRNA, Small NuclearSaccharomyces cerevisiaeSchizosaccharomycesTelomeraseMALAT1 long non-coding RNA, humanRNARNA, Long NoncodingRNA, Small NuclearTelomerasetelomerase RNA

Identifiers

PMID23754627
PMCPMC4406282
OpenAlexW2167012795

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.